/ /


Sustained drug-delivery technologies shape promising futureDevelopment of technologies for sustained drug delivery is a topic of great interest among retina specialists considering the number of chronic conditions that are managed with repeated intravitreal injections.
Corneal inlays play increasing role in presbyopiaAs the number of LASIK procedures being performed continues to fall worldwide, correction of presbyopia is receiving increasing attention as being the final frontier and “holy grail” for refractive surgery, said Wayne Crewe-Brown, MD, at Refractive Surgery 2017.
Schepens lecturer traces advent, evolution of ophthalmic trialsClinical trials are an indispensable ordeal that are the gold standard for assessing risks and benefits of treatments, said Frederick L. Ferris III, MD.
Gene therapy benefits for retinal dystrophies persist through trialResults from 3 years of follow-up in the phase III trial investigating treatment with adeno-associated viral vector delivery of human RPE65 (voretigene neparvovec, Spark Therapeutics) show this gene therapy has an acceptable safety profile.
Staying calm while navigating through LASIK complicationsEncountering complications is inevitable for anyone who performs LASIK, and when the complication occurs intraoperatively, surgeons are often faced with the need to make a decision quickly, said Priyanka Sood, MD.
RLE choice factors in benefits, risks, alternativesRemoval of the crystalline lens was developed as a procedure to treat the media opacity, but advances in surgical techniques and in pseudophakic IOL technology have increased the functional use of lens-based refractive surgery, said William F. Wiley, MD.
Phase IV study shows improved DME outcomes with fluocinolone acetonide implantThe fluocinolone acetonide 0.2 mcg/day implant (Iluvien, Alimera Sciences) offers an additional option for treating diabetic macular edema that reduces the need for subsequent therapy with anti-vascular endothelial growth factor or steroid treatment.
Basic estate planning protects individual and legacy
Integrating new technology into busy ophthalmic ASCAdopting new technologies across multiple practices using a single ambulatory surgery center can be challenging. A systematic approach leverages technology champions, employs consistent communications, and provides administrative support to secure reimbursement.
Bascom Palmer takes top honors in Ophthalmology Times Best Programs SurveyAfter a seven-year hiatus, Ophthalmology Times resumed its Best Programs Survey this fall. While a few new names popped up on the list, Bascom Palmer Eye Institute at the University of Miami Miller School of Medicine, Miami, remained at the top of the Best Overall Program category, followed again by the Wilmer Eye Institute at the Johns Hopkins University School of Medicine, Baltimore. Number three in the overall list has a new name with Dean McGee Eye Institute at the University of Oklahoma, Oklahoma City—the first time that institute has appeared in the top category since the survey’s inception 20 years ago.